RETRACTED ARTICLE: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease
Authors:
Open Access
- 16 January 2013
- journal article
- retracted article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 17 (5) , 730-742
Abstract
Background Although left ventricular hypertrophy (LVH) has been established as a predictor of cardiovascular events in chronic kidney disease (CKD), the relationship between the prevalence of LVH and CKD stage during the predialysis period has not been fully examined. Methods We measured left ventricular mass index (LVMI) in a cross-sectional cohort of participants in the Chronic Kidney Disease Japan Cohort (CKD-JAC) study in order to identify factors that are associated with increased LVMI in patients with stage 3–5 CKD. LVH was defined as LVMI > 125 g/m2 in male patients and >110 g/m2 in female patients. Results We analyzed baseline characteristics in 1185 participants (male 63.7 %, female 36.3 %). Diabetes mellitus was the underlying disease in 41.3 % of patients, and mean age was 61.8 ± 11.1 years. LVH was detected in 21.7 % of patients at baseline. By multivariate logistic analysis, independent risk factors for LVH were past history of cardiovascular disease (odds ratio [OR] 0.574; 95 % confidence interval [CI] 0.360–0.916; P = 0.020), systolic blood pressure (OR 1.179; 95 % CI 1.021–1.360; P = 0.025), body mass index (OR 1.135; 95 % CI 1.074–1.200; P < 0.001), and serum calcium level (OR 0.589; 95 % CI 0.396–0.876; P = 0.009). Conclusion Cross-sectional baseline data from the CKD-JAC study shed light on the association between LVH and risk factors in patients with decreased renal function. Further longitudinal analyses of the CKD-JAC cohort are needed to evaluate the prognostic value of LVH in CKD patients.Keywords
This publication has 32 references indexed in Scilit:
- Sex differences in hypertension-related renal and cardiovascular diseases in ItalyJournal Of Hypertension, 2012
- Cardiovascular disease in chronic kidney disease from a cardiologistʼs perspectiveCurrent Opinion in Nephrology and Hypertension, 2004
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2004
- Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and WomenJournal of the American Society of Nephrology, 2003
- Pathophysiology of cardiovascular damage in the early renal populationNephrology Dialysis Transplantation, 2001
- Cardiovascular disease determinants in chronic renal failure: clinical approach and treatmentNephrology Dialysis Transplantation, 2001
- Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for interventionAmerican Journal of Kidney Diseases, 1996
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.Circulation, 1981